Axillary dissection should not be performed in breast cancer patients with limited nodal disease to determine abemaciclib candidacy

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1183-1186
Number of pages4
JournalGland Surgery
Volume14
Issue number7
DOIs
StatePublished - Jul 31 2025

Keywords

  • axillary dissection
  • cyclin-dependent kinase 4/6 inhibitors (CDK4/6 inhibitors)
  • monarchE
  • NATALEE
  • SENOMAC

Fingerprint

Dive into the research topics of 'Axillary dissection should not be performed in breast cancer patients with limited nodal disease to determine abemaciclib candidacy'. Together they form a unique fingerprint.

Cite this